Skip to main content
. 2022 Aug 11;4(1):184. doi: 10.1007/s42399-022-01267-1

Table 3.

Comparison of symptoms, treatment, and disease course of the groups

Control group (n: 107) Study group (n: 19) P
Caugh 37% 47% 0.411
Dyspnea 34% 53% 0.120
Chest pain 5% 11% 0.310
Myalgia 32% 37% 0.674
Nasal congestion 5% 6% 0.918
Sore throat 10% 6% 0.555
İnsomnia 10% 0% 0.216
Headache 6% 16% 0.116
Diarrhea 3% 0% 0.458
Itching 13% 100%  < 0.001
Antenatal corticosteroid therapy 18% 37% 0.061
Systemic steroid therapy 30% 32% 0.837
Oxygen support 37% 53% 0.193
Admission to ICU 17% 21% 0.732
Admission to NICU 8% 15% 0.313
Preterm delivery 43% 50% 0.961
Maternal mortality 7% 15% 0.237

A p-value of <0.05 was set to boldface